Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLSTICE: Losmapimod in NSTEMI
NCT00910962Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of losmapimod in non-ST-elevation myocardial infarction (NSTEMI), sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
losmapimod
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00910962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910962.